
Infosys records poor Q4 performance; Toast’s billion-dollar India R&D plans
Hello, Investors have turned up the heat on Medikabazaar. Series C investors in the B2B medical equipment company have filed a Rs 279 crore indemnity claim following allegations of fraudulent financial reporting tied to earlier funding rounds. The …